Automated Ultrasound Systems Market Dynamics 2024

Automated Ultrasound Systems Market Dynamics 2024 - 2031

نشر بتاريخ 2024-02-26 11:28:01

937

Report Overview

The global market for automated breast ultrasound systems was valued at USD 14,24 million in 2023 and is projected to reach USD 2452 million by 2031, expanding at a compound annual growth rate (CAGR) of 12.4% during the forecast period from 2024 to 2031.

Automated Breast Ultrasound (ABUS), a widely adopted technique, has the potential to detect up to 30% more tumors in women with dense breast tissue (more glandular or fibrous than fatty), even if it’s the only additional risk factor.

For women with denser breasts, mammography may not be sufficient, and ABUS can be utilized to detect more malignancies. Ultrasound procedures do not use ionizing radiation, making ABUS a quick, painless, and efficient method for imaging dense breasts.

For More Insights Request Free Sample: https://www.datamintelligence.com/download-sample/automated-breast-ultrasound-systems-market

Market Segmentation

By Ultrasound Type

Doppler ultrasound
Color Doppler
Transvaginal ultrasound

By Application

Breast imaging
Screening

By End-User

Hospitals
Diagnostic Imaging Centers
Diagnostic Laboratories

View Full Report: https://www.datamintelligence.com/research-report/automated-breast-ultrasound-systems-market

Market Key Players

Major players are GE Healthcare, Hitachi, Ltd, Koninklijke Philips N.V., Siemens AG , SonoCiné Inc, Qview Medical, Hologic Inc, Volpara Solutions Limited, Delphinus Medical Technologies, Inc and Nova Medical Inc.